1
/
of
1
Goodfellow
Pemex (Pemetrexed)
Pemex (Pemetrexed)
Regular price
$17,250.50 USD
Regular price
Sale price
$17,250.50 USD
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
Pemex (Pemetrexed) is a potent antimetabolite chemotherapy agent indicated for the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. This prescription medication works by disrupting folate-dependent metabolic processes essential for DNA and RNA synthesis, effectively inhibiting rapid cancer cell proliferation.
Pemetrexed is typically administered intravenously as part of a combination chemotherapy regimen, often paired with cisplatin or other platinum-based agents. The medication demonstrates efficacy across multiple NSCLC histologies and has become a standard component of first-line and maintenance therapy protocols in oncology practice. Healthcare providers frequently prescribe Pemex for patients with advanced-stage malignancies where surgery or radiation therapy are not viable treatment options.
The active ingredient pemetrexed functions as a multitargeted antifolate, inhibiting thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase—enzymes critical to cancer cell survival. This multi-pathway mechanism provides superior efficacy compared to single-target agents, making it a preferred choice in comprehensive cancer treatment strategies.
Pemex requires careful dosing adjustments based on renal function, performance status, and hematologic parameters. Premedication with folic acid and vitamin B12 supplementation is standard practice to minimize toxicity and improve tolerability. Oncologists and specialized cancer care teams administer this medication in monitored clinical settings with appropriate supportive care protocols.
This product is available through licensed pharmacy channels and is intended for use under direct medical supervision only. Pemex represents a critical therapeutic option in modern cancer treatment, offering improved survival outcomes and quality of life for eligible patients with advanced lung malignancies and mesothelioma.
Pemetrexed is typically administered intravenously as part of a combination chemotherapy regimen, often paired with cisplatin or other platinum-based agents. The medication demonstrates efficacy across multiple NSCLC histologies and has become a standard component of first-line and maintenance therapy protocols in oncology practice. Healthcare providers frequently prescribe Pemex for patients with advanced-stage malignancies where surgery or radiation therapy are not viable treatment options.
The active ingredient pemetrexed functions as a multitargeted antifolate, inhibiting thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase—enzymes critical to cancer cell survival. This multi-pathway mechanism provides superior efficacy compared to single-target agents, making it a preferred choice in comprehensive cancer treatment strategies.
Pemex requires careful dosing adjustments based on renal function, performance status, and hematologic parameters. Premedication with folic acid and vitamin B12 supplementation is standard practice to minimize toxicity and improve tolerability. Oncologists and specialized cancer care teams administer this medication in monitored clinical settings with appropriate supportive care protocols.
This product is available through licensed pharmacy channels and is intended for use under direct medical supervision only. Pemex represents a critical therapeutic option in modern cancer treatment, offering improved survival outcomes and quality of life for eligible patients with advanced lung malignancies and mesothelioma.
Share
